Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
FDA defends generic drug label proposal at U.S. House hearing
Yahoo/Reuters
Wed, 04/2/14 - 07:48 am
FDA
generics
labeling
Can MannKind Shares Double Again on FDA Approval?
24/7 Wall St
Wed, 04/2/14 - 07:46 am
FDA
Afrezza
diabetes
MannKind
Pacira Up as Exparel Site Gets FDA Nod
Yahoo/Zacks.com
Wed, 04/2/14 - 07:19 am
Pacira
EXPAREL
FDA
Stallergenes gains U.S. FDA approval for Oralair allergy drug
Yahoo/Reuters
Tue, 04/1/14 - 10:25 pm
Stallergenes
FDA
Oralair
MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
Bloomberg
Tue, 04/1/14 - 10:20 pm
MannKind
inhaled insulin
Afrezza
FDA
diabetes
advisory panels
FDA finds contaminated drug ingredients at GSK Ireland plant
Yahoo/Reuters
Tue, 04/1/14 - 01:04 pm
FDA
GSK
Ireland
drug manufacturing
Just a Standard “Breakthrough”: FDA’s Unusual Designations for Novartis’ Serelaxin
Pharma and MedTech Business Intelligence
Tue, 04/1/14 - 08:12 am
FDA
Novartis
serelaxin
Mannkind Afrezza FDA Panel Live Blog
TheStreet.com
Tue, 04/1/14 - 08:07 am
FDA
Afrezza
MannKind
advisory panels
insulin
Durata's anti-infective drug shows efficacy, safety -FDA panel
Yahoo/Zacks.com
Mon, 03/31/14 - 04:39 pm
Durata
FDA
advisory panels
dalbavancin
Shares of MannKind Plummet Prior to Drug Advisory Meeting
Yahoo/Benzinga
Mon, 03/31/14 - 04:23 pm
FDA
MannKind
Afrezza
FDA panel says Cubist anti-infective shows efficacy, safety
Yahoo/Reuters
Mon, 03/31/14 - 11:49 am
FDA
Cubist Pharmaceuticals
antibiotics
tedizolid
Mannkind: The Best Afrezza FDA Panel Preview Ever
TheStreet.com
Mon, 03/31/14 - 09:53 am
FDA
Afrezza
advisory panels
diabetes
MannKind
Oxygen Biotherapeutics Inc. Provides an Update on Communication with the FDA Regarding Oxycyte Development Program; Hold Has Been Lifted
Yahoo/Benzinga
Mon, 03/31/14 - 09:44 am
FDA
Oxygen Biotherapeutics
Oxycyte
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
FOX Business
Fri, 03/28/14 - 01:00 pm
MannKind
FDA
Afrezza
insulin
diabetes
FDA And Meningitis B: Picking Winners And Losers
Forbes
Fri, 03/28/14 - 10:19 am
meningitis B
FDA
Novartis
vaccines
Bexsero
Pfizer
bivalent rLP2086
FDA Issues Proposed Rule Amending Classification and Reclassification Regulations for Medical Devices
FDA Law Blog
Fri, 03/28/14 - 10:10 am
FDA
devices
MannKind And Afrezza's NDA Evaluation: What Is The Real Justification For The Advisory Committee?
Seeking Alpha
Fri, 03/28/14 - 08:21 am
MannKind
diabetes
Afrezza
FDA
advisory panels
FDA advisers back Exact Sciences colon cancer test
Yahoo/AP
Thu, 03/27/14 - 04:59 pm
FDA
advisory panels
EXACT Sciences
colon cancer
Cologuard
FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug
Forbes
Thu, 03/27/14 - 04:58 pm
FDA
Novartis
serelaxin
acute heart failure
advisory panels
Reasanz
Three Misplaced Assumptions That Could End The Biotech Boom
Forbes
Thu, 03/27/14 - 08:15 am
biotech
R&D
FDA
Pages
« first
‹ previous
…
334
335
336
337
338
339
340
341
342
…
next ›
last »